Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-29
2007-05-29
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S343500, C514S398000
Reexamination Certificate
active
10672613
ABSTRACT:
The invention relates to the 2-mercapto-4,5-diarylimidazole derivatives of formula (I), wherein R1, R2, R3and R4are defined as in the description. The inventive compounds have an immunomodulatory and cyclooxygenase-inhibiting activity and are therefore suitable for the treatment of diseases that are associated with a disturbed immune system.
REFERENCES:
patent: 4269847 (1981-05-01), Niedballa et al.
patent: 4355039 (1982-10-01), Niedballa et al.
patent: 4440776 (1984-04-01), Niedballa et al.
patent: 4686231 (1987-08-01), Bender et al.
patent: 5318984 (1994-06-01), Billheimer et al.
patent: 5364875 (1994-11-01), Wilde
patent: 5620999 (1997-04-01), Weier et al.
patent: 01040467 (1989-02-01), None
patent: 1415725 (1996-01-01), None
patent: WO 91/10662 (1991-07-01), None
patent: WO 91/13876 (1991-09-01), None
STN CAS Accession No. 1973:72002, “Reactions with 4,5-disubstituted 2-mercaptoimidazoles and their derivatives,” Mustafa et al, Journal fuer Praktische Chemie (1972), vol. 314, No. (5-6), pp. 785-792.
STN CAS Accession No. 1983:470631, “Heterocyclic systems containing bridgehead nitrogen atom. Part XLVI . . . ” Gupta et al. Indian Journal of Chemistry, Section B. (1983), vol. 22B, No. (3), pp. 268-269.
Maduskuie, Thomas P., Jr., et al., “Design, Synthesis, and Structure-Activity Relationship Studies for a New Imidazole Series of J774 Macrophage Specific Acyl-CoA:Cholesterol Acyltransferase (ACAT) Inhibitors,” J. Med. Chem., 1995, pp. 1067-1083, vol. 38, XP001084249, American Chemical Society, U.S.A.
Mustafa, A., etal., “Reactions with 4,5-Disubstituted 2-Mercaptoimidazoles and their Derivatives,” J. Prakt. Chem., 1972, pp. 785-792, vol. 314, XP-001088374, J. A. Barth, Leipzig.
Gupta, G. D., et al., “Heterocyclic Systems Containing Bridgehead Nitrogen Atom. Part XLVI, Reaction of 4,5-disubstituted 2-mercaptoimidazoles with alpha-halogenoketones and 1,2-dibromoethane,” Indian J. Chemical, Chemical Abstracts, Aug. 29, 1983, vol. 99, No. 9, Abstract No. 70631, Columbus, Ohio.
Salama, M.A., et al., “Synthesis and reactions of 4,5-diaryl-2-mercaptoimidazoles,” Chemical Abstracts, Nov. 7, 1988, p. 710, vol. 109, No. 19, Abstract No. 170305, Columbus, Ohio.
Wilde, Richard G., et al., “Acyl CoA: Cholesterol Acyltransferase (ACAT) Inhibitors: Heterocyclic Bioisosteres for the Urea Group in DuP 128,” Bioorganic & Medicinal Chemistry Letters, Jan. 19, 1995, pp. 177-180, vol. 5, No. 2, XP004135812, Elsevier Science Ltd., Great Britain.
International Search Report from corresponding International Application No. PCT/EP02/03264 dated Aug. 2, 2002.
Dannhardt Gerd
Hahn Linda
Alston & Bird LLP
Beiersdorf AG
Coppins Janet L.
LandOfFree
2-mercapto-4,5-diarylimidazole derivatives and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-mercapto-4,5-diarylimidazole derivatives and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-mercapto-4,5-diarylimidazole derivatives and the use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753683